OTCMKTS:CVALF Covalon Technologies (CVALF) Stock Price, News & Analysis $1.79 -0.04 (-1.96%) As of 08/1/2025 03:15 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesShort InterestBuy This Stock About Covalon Technologies Stock (OTCMKTS:CVALF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Covalon Technologies alerts:Sign Up Key Stats Today's Range$1.79▼$1.8750-Day Range$1.66▼$2.0052-Week Range$1.46▼$3.08Volume14,363 shsAverage Volume5,489 shsMarket Capitalization$49.19 millionP/E Ratio19.94Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada. Read More Receive CVALF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address CVALF Stock News HeadlinesCovalon Technologies (OTCMKTS:CVALF) Shares Down 3.1% - Here's What HappenedJuly 29, 2025 | americanbankingnews.comCovalon Technologies Ltd. (CVALF) Q2 2025 Earnings Call TranscriptMay 28, 2025 | seekingalpha.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. | Brownstone Research (Ad)Covalon Reports Fifth Consecutive Quarter of Positive EarningsMay 28, 2025 | financialpost.comFCovalon Reports Fifth Consecutive Quarter of Positive EarningsMay 28, 2025 | financialpost.comFCovalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line GuardMay 27, 2025 | finance.yahoo.comCovalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing OpportunitiesMay 20, 2025 | financialpost.comFCovalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing OpportunitiesMay 20, 2025 | financialpost.comFSee More Headlines CVALF Stock Analysis - Frequently Asked Questions How have CVALF shares performed this year? Covalon Technologies' stock was trading at $2.24 at the start of the year. Since then, CVALF shares have decreased by 19.9% and is now trading at $1.7941. How were Covalon Technologies' earnings last quarter? Covalon Technologies Ltd. (OTCMKTS:CVALF) announced its earnings results on Wednesday, May, 28th. The company reported $0.01 earnings per share for the quarter, hitting analysts' consensus estimates of $0.01. The firm had revenue of $5.27 million for the quarter, compared to analysts' expectations of $7.67 million. Covalon Technologies had a net margin of 10.95% and a trailing twelve-month return on equity of 13.40%. How do I buy shares of Covalon Technologies? Shares of CVALF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/28/2025Today8/03/2025Next Earnings (Estimated)8/20/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryN/A Current SymbolOTCMKTS:CVALF CIKN/A Webwww.covalon.com Phone(905) 568-8400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)$0.09 Trailing P/E Ratio19.94 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.96 million Net Margins10.95% Pretax Margin10.93% Return on Equity13.40% Return on Assets11.59% Debt Debt-to-Equity RatioN/A Current Ratio8.39 Quick Ratio6.09 Sales & Book Value Annual Sales$22.91 million Price / Sales2.15 Cash Flow$0.10 per share Price / Cash Flow18.29 Book Value$0.74 per share Price / Book2.42Miscellaneous Outstanding Shares27,420,000Free FloatN/AMarket Cap$49.19 million OptionableNot Optionable Beta0.64 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:CVALF) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Create New Advertiser | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Covalon Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Covalon Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.